Detalles de la búsqueda
1.
Optimizing metabolic stability of phosphodiesterase 5 inhibitors: Discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity.
Bioorg Med Chem Lett
; 92: 129409, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453616
2.
The 5HT2b Receptor in Alzheimer's Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction.
J Alzheimers Dis
; 98(4): 1349-1360, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578894
3.
Intracellular accumulation of tau oligomers in astrocytes and their synaptotoxic action rely on Amyloid Precursor Protein Intracellular Domain-dependent expression of Glypican-4.
Prog Neurobiol
; 227: 102482, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321444
4.
Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
Biochem Pharmacol
; 176: 113818, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31978378
5.
Tau is not necessary for amyloid-ß-induced synaptic and memory impairments.
J Clin Invest
; 130(9): 4831-4844, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544084
6.
Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Mol Neurodegener
; 14(1): 26, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248451
7.
Correction: Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.
Mol Neurodegener
; 19(1): 39, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685083
8.
Vitamin C, Aging and Alzheimer's Disease.
Nutrients
; 9(7)2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28654021
Resultados
1 -
8
de 8
1
Próxima >
>>